Specific immunoprotection with 3 M KCI solubilized tumor antigen
- 31 March 1975
- journal article
- Published by Elsevier in Journal of Surgical Research
- Vol. 18 (3) , 263-269
- https://doi.org/10.1016/0022-4804(75)90150-x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Tumor-Specific and Allospecific Immunogenicity of Soluble Extracts from Chemically Induced Murine SarcomasThe Journal of Immunology, 1974
- Immunotherapy of Cancer: Immunospecific Rejection of Tumors in Recipients of Neuraminidase-Treated Tumor Cells Plus BCGScience, 1971
- Serum mediated inhibition of cellular immunity to methylcholanthrene-induced murine sarcomasCellular Immunology, 1970
- Soluble tumor-specific transplantation antigens from methylcholanthrens induced guinea pig sarcomasCancer, 1970
- ACTIVE IMMUNOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKÆMIAThe Lancet, 1969
- Tumour specific immunogenicity of methylcholanthrene-induced sarcoma cells after incubation in neuraminidase.British Journal of Cancer, 1969
- Cellular Immunity Against Tumor AntigensAdvances in Cancer Research, 1969
- Delayed Hypersensitivity and Transplantation Immunity elicited by Soluble Antigens of Chemically Induced Tumours in Inbred Guinea-pigsNature, 1968
- ‘Actively Acquired Tolerance’ of Foreign CellsNature, 1953
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951